Normal immunoglobulin G protects against experimental allergic encephalomyelitis by inducing transferable T cell unresponsiveness to myelin basic protein (Q47915965)

From Wikidata

Jump to navigation Jump to search

scientific article published in June 1998

Language	Label	Description	Also known as
English	Normal immunoglobulin G protects against experimental allergic encephalomyelitis by inducing transferable T cell unresponsiveness to myelin basic protein	scientific article published in June 1998

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/9645363

Normal immunoglobulin G protects against experimental allergic encephalomyelitis by inducing transferable T cell unresponsiveness to myelin basic protein (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/9645363

author name string

Pashov A

1

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/9645363

Dubey C

2

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/9645363

Kaveri SV

3

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/9645363

Lectard B

4

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/9645363

Huang YM

5

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/9645363

Kazatchkine MD

6

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/9645363

Bellon B

7

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/9645363

language of work or name

0 references

publication date

1 June 1998

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/9645363

European Journal of Immunology

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/9645363

28

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/9645363

6

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/9645363

1823-1831

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/9645363

T cells responsive to myelin basic protein in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199806%2928%3A06%3C1823%3A%3AAID-IMMU1823%3E3.0.CO%3B2-F

21 January 2018

The T lymphocyte in experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199806%2928%3A06%3C1823%3A%3AAID-IMMU1823%3E3.0.CO%3B2-F

21 January 2018

Experimental autoimmune encephalomyelitis as a model of immune-mediated CNS disease

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199806%2928%3A06%3C1823%3A%3AAID-IMMU1823%3E3.0.CO%3B2-F

21 January 2018

Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199806%2928%3A06%3C1823%3A%3AAID-IMMU1823%3E3.0.CO%3B2-F

21 January 2018

Manipulating the Immune System with Immune Globulin

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199806%2928%3A06%3C1823%3A%3AAID-IMMU1823%3E3.0.CO%3B2-F

21 January 2018

Intravenous immunoglobulins (IVIg) in the treatment of autoimmune diseases

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199806%2928%3A06%3C1823%3A%3AAID-IMMU1823%3E3.0.CO%3B2-F

21 January 2018

High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199806%2928%3A06%3C1823%3A%3AAID-IMMU1823%3E3.0.CO%3B2-F

21 January 2018

Plasma and gamma-globulin infusion in chronic inflammatory polyneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199806%2928%3A06%3C1823%3A%3AAID-IMMU1823%3E3.0.CO%3B2-F

21 January 2018

Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gamma globulin

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199806%2928%3A06%3C1823%3A%3AAID-IMMU1823%3E3.0.CO%3B2-F

21 January 2018

Modulation of autoimmunity by intravenous immune globulin through interaction with the function of the immune/idiotypic network

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199806%2928%3A06%3C1823%3A%3AAID-IMMU1823%3E3.0.CO%3B2-F

21 January 2018

Intravenous gammaglobulin treatment in multiple sclerosis and experimental autoimmune encephalomyelitis: delineation of usage and mode of action

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199806%2928%3A06%3C1823%3A%3AAID-IMMU1823%3E3.0.CO%3B2-F

21 January 2018

Beneficial effect of human therapeutic intravenous immunoglobulins (IVIg) in mercuric-chloride-induced autoimmune disease of Brown-Norway rats

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199806%2928%3A06%3C1823%3A%3AAID-IMMU1823%3E3.0.CO%3B2-F

21 January 2018

Pooled human IgG modulates cytokine production in lymphocytes and monocytes.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199806%2928%3A06%3C1823%3A%3AAID-IMMU1823%3E3.0.CO%3B2-F

21 January 2018

Modulation of immunoglobulin production and cytokine mRNA expression in peripheral blood mononuclear cells by intravenous immunoglobulin

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199806%2928%3A06%3C1823%3A%3AAID-IMMU1823%3E3.0.CO%3B2-F

21 January 2018

Antibodies to the CD5 molecule in normal human immunoglobulins for therapeutic use (intravenous immunoglobulins, IVIg)

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199806%2928%3A06%3C1823%3A%3AAID-IMMU1823%3E3.0.CO%3B2-F

21 January 2018

Antibodies to a conserved region of HLA class I molecules, capable of modulating CD8 T cell-mediated function, are present in pooled normal immunoglobulin for therapeutic use.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199806%2928%3A06%3C1823%3A%3AAID-IMMU1823%3E3.0.CO%3B2-F

21 January 2018

Human autoantibodies reactive with synthetic autoantigens from T-cell receptor beta chain

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199806%2928%3A06%3C1823%3A%3AAID-IMMU1823%3E3.0.CO%3B2-F

21 January 2018

Intravenous immunoglobulin treatment of experimental T cell-mediated autoimmune disease. Upregulation of T cell proliferation and downregulation of tumor necrosis factor alpha secretion

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199806%2928%3A06%3C1823%3A%3AAID-IMMU1823%3E3.0.CO%3B2-F

21 January 2018

CD28/B7 system of T cell costimulation

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199806%2928%3A06%3C1823%3A%3AAID-IMMU1823%3E3.0.CO%3B2-F

21 January 2018

Induction of non-responsiveness in human allergen-specific type 2 T helper cells

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199806%2928%3A06%3C1823%3A%3AAID-IMMU1823%3E3.0.CO%3B2-F

21 January 2018

Mechanisms of peripheral tolerance and suppression induced by monoclonal antibodies to CD4 and CD8.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199806%2928%3A06%3C1823%3A%3AAID-IMMU1823%3E3.0.CO%3B2-F

21 January 2018

Immunoglobulin-mediated prevention of autoimmune diabetes in the non-obese diabetic (NOD) mouse.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199806%2928%3A06%3C1823%3A%3AAID-IMMU1823%3E3.0.CO%3B2-F

21 January 2018

Th1/Th2 cytokine gene expression after mercuric chloride in susceptible and resistant rat strains

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199806%2928%3A06%3C1823%3A%3AAID-IMMU1823%3E3.0.CO%3B2-F

21 January 2018

Acute experimental allergic encephalomyelitis in SJL/J mice induced by a synthetic peptide of myelin proteolipid protein

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199806%2928%3A06%3C1823%3A%3AAID-IMMU1823%3E3.0.CO%3B2-F

21 January 2018

Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: preliminary analysis of MOG T cell epitopes

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199806%2928%3A06%3C1823%3A%3AAID-IMMU1823%3E3.0.CO%3B2-F

21 January 2018

High-dose intravenous gammaglobulin for Kawasaki disease

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199806%2928%3A06%3C1823%3A%3AAID-IMMU1823%3E3.0.CO%3B2-F

21 January 2018

Human immunoglobulin preparations for intravenous use prevent experimental autoimmune uveoretinitis

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199806%2928%3A06%3C1823%3A%3AAID-IMMU1823%3E3.0.CO%3B2-F

21 January 2018

Monoclonal, natural antibodies prevent development of diabetes in the non-obese diabetic (NOD) mouse

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199806%2928%3A06%3C1823%3A%3AAID-IMMU1823%3E3.0.CO%3B2-F

21 January 2018

Suppression of Cytokine-Dependent Human T-Cell Proliferation by Intravenous Immunoglobulin

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199806%2928%3A06%3C1823%3A%3AAID-IMMU1823%3E3.0.CO%3B2-F

21 January 2018

Protection against experimental autoimmune encephalomyelitis requires both CD4+ T suppressor cells and myelin basic protein-primed B cells

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199806%2928%3A06%3C1823%3A%3AAID-IMMU1823%3E3.0.CO%3B2-F

21 January 2018

Active suppression induced by anti-CD4

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199806%2928%3A06%3C1823%3A%3AAID-IMMU1823%3E3.0.CO%3B2-F

21 January 2018

Cytokine-related syndrome following injection of anti-CD3 monoclonal antibody: further evidence for transient in vivo T cell activation

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199806%2928%3A06%3C1823%3A%3AAID-IMMU1823%3E3.0.CO%3B2-F

21 January 2018

An alternative quantitative polymerase chain reaction method

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199806%2928%3A06%3C1823%3A%3AAID-IMMU1823%3E3.0.CO%3B2-F

21 January 2018

Identifiers

10.1002/(SICI)1521-4141(199806)28:06<1823::AID-IMMU1823>3.0.CO;2-F

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/9645363

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/9645363

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47915965&oldid=2175690840"